دورية أكاديمية

Long Lasting Antibodies From Convalescent Pertussis Patients Induce ROS Production and Bacterial Killing by Human Neutrophils.

التفاصيل البيبلوغرافية
العنوان: Long Lasting Antibodies From Convalescent Pertussis Patients Induce ROS Production and Bacterial Killing by Human Neutrophils.
المؤلفون: Kroes MM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.; Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., van Vliet LC; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands., Jacobi RHJ; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands., Kuipers B; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands., Pieren DKJ; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands., Miranda-Bedate A; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands., van Els CACM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.; Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Pinelli E; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
المصدر: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2022 May 12; Vol. 12, pp. 888412. Date of Electronic Publication: 2022 May 12 (Print Publication: 2022).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Lausanne : Frontiers Media SA
مواضيع طبية MeSH: Whooping Cough*/prevention & control, Bordetella pertussis ; Humans ; Neutrophils ; Pertussis Vaccine ; Reactive Oxygen Species
مستخلص: Pertussis is a respiratory infection caused by the Gram-negative bacterium Bordetella pertussis . Despite high vaccination coverage this disease remains a public health concern worldwide. A better understanding of the protective immune responses to B. pertussis is required for the development of improved vaccines. The aim of this study was to determine the production of reactive oxygen species (ROS) by human neutrophils in response to B. pertussis and to determine the contribution of opsonizing antibodies from convalescent pertussis patients in this response. The serum samples from convalescent patients were taken at <3, 9, 18 and 36 months after diagnosis of pertussis. Also included were sera from healthy age-matched controls. We show that neutrophils produced high levels of ROS in response to opsonized, compared to non-opsonized, B. pertussis and that this effect was independent of the time the convalescent serum samples were taken. This indicates the presence of functional opsonizing antibodies up to 3 years after B. pertussis infection. While opsonization of B. pertussis with serum samples from uninfected controls also induced ROS production, sera from infected individuals induced significantly higher ROS levels. Spearman correlations analysis showed that IgG antibodies targeting fimbriae3 followed by pertactin, and BrkA correlate with ROS production. Additionally, we observed that neutrophils killed opsonized B. pertussis in a ROS-dependent manner. Searching for other antigen-specific antibodies from convalescent pertussis patients involved in ROS production by neutrophils may assist in the identification of novel antigens to improve the current pertussis vaccines.
Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2022 Kroes, van Vliet, Jacobi, Kuipers, Pieren, Miranda-Bedate, van Els and Pinelli.)
References: Lancet Infect Dis. 2017 Sep;17(9):974-980. (PMID: 28623146)
Blood. 2008 Aug 15;112(4):935-45. (PMID: 18684880)
Nat Rev Immunol. 2013 May;13(5):349-61. (PMID: 23618831)
Nat Rev Immunol. 2020 Sep;20(9):515-516. (PMID: 32728221)
Infect Immun. 2013 Jul;81(7):2371-8. (PMID: 23630952)
J Infect. 2016 Jul 5;72 Suppl:S34-40. (PMID: 27161992)
Vaccines (Basel). 2020 Jul 30;8(3):. (PMID: 32751680)
J Exp Med. 2001 Aug 20;194(4):519-27. (PMID: 11514607)
Nat Rev Microbiol. 2014 Apr;12(4):274-88. (PMID: 24608338)
Clin Infect Dis. 2008 Aug 1;47(3):328-38. (PMID: 18558873)
Pathog Dis. 2015 Dec;73(9):ftv081. (PMID: 26432818)
J Immunol. 2001 Dec 1;167(11):6545-51. (PMID: 11714823)
Sci Rep. 2017 Jan 16;7:40328. (PMID: 28091579)
J Leukoc Biol. 2013 Oct;94(4):657-70. (PMID: 23610146)
Sci Rep. 2018 Aug 13;8(1):12039. (PMID: 30104573)
Front Immunol. 2019 Aug 27;10:2030. (PMID: 31507615)
Infect Immun. 2000 Feb;68(2):956-9. (PMID: 10639471)
Emerg Microbes Infect. 2021 Dec;10(1):1358-1368. (PMID: 34132167)
Front Microbiol. 2020 Aug 27;11:2108. (PMID: 32983069)
Front Cell Infect Microbiol. 2017 Aug 25;7:373. (PMID: 28890882)
Nat Rev Immunol. 2018 Feb;18(2):134-147. (PMID: 28990587)
PLoS One. 2010 Dec 01;5(12):e14183. (PMID: 21152071)
Infect Immun. 2001 Apr;69(4):2017-24. (PMID: 11254553)
Cell. 2006 Feb 24;124(4):783-801. (PMID: 16497588)
J Leukoc Biol. 2006 Jan;79(1):87-94. (PMID: 16244110)
Infect Immun. 2009 Mar;77(3):1182-8. (PMID: 19103765)
Infect Immun. 2000 Jul;68(7):4289-96. (PMID: 10858247)
فهرسة مساهمة: Keywords: Bordetella pertussis; Reactive Oxygen Species (ROS); antibody; neutrophil; opsonization
المشرفين على المادة: 0 (Pertussis Vaccine)
0 (Reactive Oxygen Species)
تواريخ الأحداث: Date Created: 20220601 Date Completed: 20220603 Latest Revision: 20220808
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9135168
DOI: 10.3389/fcimb.2022.888412
PMID: 35646735
قاعدة البيانات: MEDLINE
الوصف
تدمد:2235-2988
DOI:10.3389/fcimb.2022.888412